Erratum: Biomimetic Solid Lipid Nanoparticles for Oral Bioavailability Enhancement of Low Molecular Weight Heparin and Its Lipid Conjugates: In Vitro and in Vivo Evaluation (Molecular Pharmaceutics (2011) 8: 4 (1314−1321) DOI: 10.1021/mp200109m);Biomimetic solid lipid nanoparticles for oral bioavailability enhancement of low molecular weight heparin and its lipid conjugates: In vitro and in vivo evaluation

Molecular Pharmaceutics

Volumn 8, Issue 4, 2011, Pages 1314-1321

  Paliwal, Rishi ^a   Paliwal, Shivani R ^a   Agrawal, Govind P ^a   Vyas, Suresh P ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

anticoagulant; drug lipid conjugate; low molecular weight heparin; oral delivery; solid lipid nanoparticles; transcellular absorption

Indexed keywords

BIOMIMETIC MATERIAL; LOW MOLECULAR WEIGHT HEPARIN; MYRISTIC ACID; PALMITIC ACID; PHOSPHATIDYLCHOLINE; SOLID LIPID NANOPARTICLE; STEARIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG RELEASE; DRUG SAFETY; DRUG SYNTHESIS; FEMALE; GASTROINTESTINAL TOXICITY; IN VITRO STUDY; IN VIVO STUDY; MALE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; ZETA POTENTIAL;

EID: 79961059160     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.0c00426     Document Type: Erratum

References (39)

1. Arbit, E.; Goldberg, M.; Gomez-Orellana, I.; Majuru, S. Oral heparin: status review Thromb. J. 2006, 10, 4-6
2. Paliwal, R.; Paliwal, S. R.; Agrawal, G. P.; Vyas, S. P. Recent advances in search of oral heparin therapeutics. Med. Res. Rev. 2011, in press.
3. Homar, M.; Cegnar, M.; Kotnik, M.; Peternel, L. Toward effective long-term prevention of thromboembolism: novel oral anticoagulant delivery systems Semin. Thromb. Hemostasis 2010, 36, 113-122
4. Lanke, S. S.; Gayakwad, S. G.; Strom, J. G.; D'souza, M. J. Oral delivery of low molecular weight heparin microspheres prepared using biodegradable polymer matrix system J. Microencapsulation 2009, 26, 493-500
5. Meissner, Y.; Ubrich, N.; Ghazouani, F.; Maincent, P.; Lamprecht, A. Low molecular weight heparin loaded pH-sensitive microparticles Int. J. Pharm. 2007, 335, 147-153 (Pubitemid 46505068)
6. Motlekar, N. Optimization of experimental parameters for the production of LMWH-loaded polymeric microspheres Drug Des. Dev. Ther. 2009, 2, 39-47
7. Chen, M. C.; Wong, H. S.; Lin, K. J.; Chen, H. L.; Wey, S. P.; Sonaje, K.; Lin, Y. H.; Chu, C. Y.; Sung, H. W. The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin Biomaterials 2009, 30, 6629-6637
8. Goldberg, M.; Gomez-Orellana, I. Challenges for the oral delivery of macromolecules Nat. Rev. Drug Discovery 2003, 2, 289-295 (Pubitemid 37361687)
9. Baughman, R. A.; Kapoor, S. C.; Agarwal, R. K.; Kisicki, J.; Catella-Lawson, F.; FitzGerald, G. A. Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans Circulation 1998, 98, 1610-1615 (Pubitemid 28500382)
10. Chandy, T.; Rao, G. H.; Wilson, R. F.; Das, G. S. Delivery of LMW heparin via surface coated chitosan/peg-alginate microspheres prevents thrombosis Drug Delivery 2002, 9, 87-96 (Pubitemid 34606532)
11. Dunn, A. Oral heparin (Emisphere) IDrugs 2000, 3, 817-824
12. Hoffart, V.; Lamprecht, A.; Maincent, P.; Lecompte, T.; Vigneron, C.; Ubrich, N. Oral bioavailability of a low molecular weight heparin using a polymeric delivery system J. Controlled Release 2006, 113, 38-42 (Pubitemid 43818166)
13. Hayes, P. Y.; Ross, B. P.; Thomas, B. G.; Toth, I. Polycationic lipophilic-core dendrons as penetration enhancers for the oral administration of low molecular weight heparin Bioorg. Med. Chem. 2006, 14, 143-152 (Pubitemid 41635478)
14. Ito, Y.; Kusawake, T.; Prasad, Y. V.; Sugioka, N.; Shibata, N.; Takada, K. Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies Int. J. Pharm. 2006, 317, 114-119
15. Jiao, Y.; Ubrich, N.; Marchand-Arvier, M.; Vigneron, C.; Hoffman, M.; Lecompte, T.; Maincent, P. In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits Circulation 2002, 105, 230-235 (Pubitemid 34084324)
16. Kim, S. K.; Lee, D. Y.; Lee, E.; Lee, Y. K.; Kim, C. Y.; Moon, H. T.; Byun, Y. Absorption study of deoxycholic acid-heparin conjugate as a new form of oral anti-coagulant J. Controlled Release 2007, 120, 4-10 (Pubitemid 46874613)
17. Lamprecht, A.; Ubrich, N.; Maincent, P. Oral low molecular weight heparin delivery by microparticles from complex coacervation Eur. J. Pharm. Biopharm. 2007, 67, 632-638 (Pubitemid 47576610)
18. Lee, D. Y.; Lee, J.; Lee, S.; Kim, S. K.; Byun, Y. Liphophilic complexation of heparin based on bile acid for oral delivery J. Controlled Release 2007, 123, 39-45 (Pubitemid 47444386)
19. Leone-Bay, A.; Paton, D. R.; Weidner, J. J. The development of delivery agents that facilitate the oral absorption of macromolecular drugs Med. Res. Rev. 2000, 20, 169-186 (Pubitemid 30134324)
20. Rivera, T. M.; Leone-Bay, A.; Paton, D. R.; Leipold, H. R.; Baughman, R. A. Oral delivery of heparin in combination with sodium N-[8-(2-hydroxybenzoyl) amino]caprylate: pharmacological considerations Pharm. Res. 1997, 14, 1830-1834
21. Pineo, G.; Hull, R.; Marder, V. Oral delivery of heparin: SNAC and related formulations Best Pract. Res., Clin. Haematol. 2004, 17, 153-160 (Pubitemid 38780073)
22. Motlekar, N. A.; Srivenugopal, K. S.; Wachtel, M. S.; Youan, B. B. Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels J. Drug Targeting 2005, 13, 573-583 (Pubitemid 43101956)
23. Motlekar, N. A.; Srivenugopal, K. S.; Wachtel, M. S.; Youan, B. B. Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer Drug Dev. Res. 2006, 67, 166-174
24. Motlekar, N. A.; Fasano, A.; Wachtel, M. S.; Youan, B. B. Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin J. Drug Targeting 2006, 14, 321-329 (Pubitemid 44173298)
25. Thanou, M.; Henderson, S.; Kydonieus, A.; Elson, C. N-sulfonato-N,O- carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules J. Controlled Release 2007, 117, 171-178 (Pubitemid 46161881)
26. Paliwal, R.; Rai, S.; Vaidya, B.; Khatri, K.; Goyal, A. K.; Mishra, N.; Mehta, A.; Vyas, S. P. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery Nanomed.: Nanotechnol., Biol., Med. 2009, 5, 184-191
27. Rai, S.; Paliwal, R.; Gupta, P. N.; Khatri, K.; Goyal, A. K.; Vaidya, B.; Vyas, S. P. Solid Lipid Nanoparticles (SLNs) as a Rising Tool in Drug Delivery Science: One Step Up in Nanotechnology Curr. Nanosci. 2008, 4, 30-44 (Pubitemid 351513459)
28. Paliwal, R.; Rai, S.; Vyas, S. P. Lipid drug conjugate (LDC) nanoparticles as autolymphotrophs for oral delivery of methotrexate J. Biomed. Nanotechnol. 2011, 7, 130-131
29. Ross, B. P.; Toth, I. Gastrointestinal absorption of heparin by lipidization or coadministration with penetration enhancers Curr. Drug Delivery 2005, 2, 277-287 (Pubitemid 40944000)
30. Lee, Y. K.; Kim, S. K.; Lee, D. Y.; Lee, S.; Kim, C. Y.; Shin, H. C.; Moon, H. T.; Byun, Y. Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys J. Controlled Release 2006, 111, 290-298
31. Lee, Y.; Kim, S. H.; Byun, Y. Oral delivery of new heparin derivatives in rats Pharm. Res. 2000, 17, 1259-1264
32. Lee, Y.; Nam, J. H.; Shin, H. C.; Byun, Y. Conjugation of low-molecular-weight heparin and deoxycholic acid for the development of a new oral anticoagulant agent Circulation 2001, 104, 3116-3120 (Pubitemid 34014067)
33. Hu, F. Q.; Yuan, H.; Zhang, H. H.; Fang, M. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization Int. J. Pharm. 2002, 239, 121-128 (Pubitemid 34615801)
34. Motlekar, N. A.; Youan, B. B. The quest for non-invasive delivery of bioactive macromolecules: a focus on heparins J. Controlled Release 2006, 113, 91-101 (Pubitemid 43928148)
35. Kast, C. E.; Guggi, D.; Langoth, N.; Bernkop-Schnürch, A. Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil Pharm. Res. 2003, 20, 931-936 (Pubitemid 36628442)
36. Leone-Bay, A.; Paton, D. R.; Freeman, J.; Lercara, C.; O'Toole, D.; Gschneidner, D.; Wang, E.; Harris, E.; Rosado, C.; Rivera, T.; DeVincent, A.; Tai, M.; Mercogliano, F.; Agarwal, R.; Leipold, H.; Baughman, R. A. Synthesis and evaluation of compounds that facilitate the gastrointestinal absorption of heparin J. Med. Chem. 1998, 41, 1163-1171 (Pubitemid 28207392)
37. Kim, S. K.; Lee, E. H.; Vaishali, B.; Lee, S.; Lee, Y. K.; Kim, C. Y.; Moon, H. T.; Byun, Y. Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates J. Controlled Release 2005, 105, 32-42 (Pubitemid 40805473)
38. Kim, S. K.; Vaishali, B.; Lee, E.; Lee, S.; Lee, Y. K.; Kumar, T. S.; Moon, H. T.; Byun, Y. Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation Thromb. Res. 2006, 117, 419-427 (Pubitemid 43197494)
39. Paliwal, R.; Paliwal, S. R.; Mishra, N.; Mehta, A.; Vyas, S. P. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate Int. J. Pharm. 2009, 380, 181-188